Mehalick David (CIK 0001846623)

Latest company ownership

Shares held
2,782,615
Last filed at
Jan 9, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 5, 2024 Jan 9, 2024 Coeptis Therapeutics Holdings, Inc. CEO Buy 68.8 +25,054 0.91% ✗ $16.7K